Explain Myopia Risk to Parents: A Clear Consultation Framework

Begin with the question the family brought

A parent asking whether the prescription changed may want a different explanation from a parent worried about a relative's retinal disease. Ask what they have heard, what they understand so far and what matters most to them.

Explain the child's current findings before moving to future possibilities. Identify what was measured, what has changed and what remains uncertain. Separate difficulty seeing today from the clinical discussion about slowing future progression.

Use language the child can join. “We are checking how your eyes are changing and how to help you see” can open a conversation without making the child feel responsible for the result. Older children may have their own questions about school, sport, appearance or daily care.

Do not begin with the most frightening complication or a population forecast. A long-term association can be relevant, but it is not a diagnosis or a personal prediction. Establish the immediate decision before choosing which risk information the family needs.

Keep three different claims in separate lanes

The consultation often includes current measurements, evidence about future risk and evidence about treatment. Each has a different basis. State which kind of information you are discussing.

A measured refractive change is an observation under particular test conditions. An association between greater myopia and later disease describes groups, with uncertainty about one person's future. A trial result describes an intervention, comparator, population and follow-up period.

Avoid moving silently between those claims. A treatment trial that shows a smaller average change in eye length over several years does not directly establish the same percentage reduction in a child's lifetime risk of every complication.

The IMI 2025 Digest supports individualized decisions and attention to outcomes beyond a single number, including safety, vision and treatment acceptance. Use that broader view to explain why the plan considers practical needs as well as progression measurements. ^[3]

Present numbers with the context still attached

When numerical evidence is relevant, keep the denominator and time period visible. Explain whether the outcome is new onset, refractive change, axial growth, an adverse event or something else.

NICE recommends absolute risk, consistent denominators and defined time periods for risk communication. Natural frequencies can help people understand event rates, while presenting both positive and negative framing can prevent a one-sided impression. ^[1]

Do not turn every outcome into a percentage. A continuous change in millimeters is not an event count. If a study reports a mean difference, show that difference with its units and uncertainty, and explain what was measured.

For a relative reduction, also show the underlying comparison and the absolute difference when available. State whether a figure is a group average and whether the child resembles the study population. An apparently precise number can still be a poor estimate for a different patient or product.

Explain uncertainty without making the answer unusable

A useful explanation can say what is known, what is less certain and what the next assessment is meant to resolve. Uncertainty does not require abandoning a recommendation; it requires being clear about its basis.

For example, the clinician may recommend an option because it fits the child's findings and has relevant evidence, while explaining that the individual's response cannot be guaranteed. The next review checks the response and safety rather than proving that the original choice was wrong if change continues.

Separate uncertainty in evidence from a lack of information in the record. If prior measurements are missing or not comparable, say that. If trials differ by population or formulation, explain that distinction. “We need another measurement” and “the research is mixed” are different messages.

Avoid absolute phrases that close discussion: “this will stop myopia,” “nothing can be done,” or “this is completely safe.” Give a recommendation and a practical reason, with enough room for the family to ask questions.

Put benefits, harms and work beside one another

Families need to understand the routine they would be agreeing to, not only the hoped-for clinical effect. Explain how the option is used, what follow-up involves, what adverse effects or practical difficulties can occur and what alternatives are suitable.

Ask about the household's actual circumstances. Cost, transport, language, sensory needs, school and caregiver availability may change what is feasible. Do not frame these concerns as a lack of motivation.

AHRQ's informed-choice training emphasizes meaningful discussion, accessible information and checking understanding as information is shared. A signature is a record of consent; it does not by itself establish that the benefits, risks and alternatives were understood. ^[2]

Make the recommendation distinct from the sales process. Explain fee scope and clinical alternatives even when a package is available. A family should be able to understand what they are accepting, declining or choosing to discuss later.

The illustrative family and clinician are fictional. The image represents a conversation, not an actual consultation, testimonial or result.

Check the explanation rather than asking for reassurance

“Does that make sense?” often produces a yes, even when the plan remains unclear. Ask the family to describe the next step or explain the purpose of a treatment in their own words.

Frame the request as a check on your explanation: “I want to be sure I explained this clearly. How would you describe the plan at home?” Allow them to use the written material. If something is misunderstood, explain it differently and check again. This is the purpose of teach-back. ^[4]

Include the child at a suitable level. The parent may describe appointments and supplies while the child describes the part they will do. Do not expect either person to repeat technical vocabulary as proof of understanding.

Document the misunderstanding that was clarified when it matters for care. A generic “understands” tick is less useful than knowing that the family initially confused ordinary correction with progression management and can now explain the difference.

Leave a written plan that another caregiver can use

The take-home plan should identify the decision, practical instructions, next review and contact routes. Keep it consistent with the prescription and any product-specific instructions.

Write down the family's unresolved questions. If the plan is to defer a decision, say what happens meanwhile and when the conversation will resume. If another opinion is wanted, explain the record-sharing process and appropriate next step.

Avoid recording a family preference as a clinical conclusion. “The parent would like fewer daily tasks” is different from “this option is unsuitable.” Show how preferences and examination findings contributed to the recommendation.

For broader information, the American Academy of Orthokeratology and Myopia Control (AAOMC) offers practitioner and patient resources. Its inclusion is a resource choice, not an endorsement of this website or the specific recommendation being discussed. ^[5]

Adapt the consultation when numbers are not the main barrier

A family may understand a chart but still be unable to arrange the proposed routine. Another may need an interpreter or accessible format before a chart is useful. Check the type of support needed rather than adding more detail by default.

Use short explanations with a clear purpose. Discuss one decision, check understanding, then build on it. A page of competing percentages is not automatically balanced communication; it can obscure the actual choice.

Respect a family's wish to ask more questions or take time when clinically appropriate. Explain any time-sensitive concern clearly, without using urgency as commercial pressure. The clinician should distinguish an urgent symptom from a decision that can be considered thoughtfully.

Bring the discussion back to the child: what needs to happen now, what is the aim of the proposed care, and what will be reviewed? Those questions help turn evidence into a plan people can use.

Review the conversation at the next visit

Ask what the family remembers the treatment was intended to do. A changing prescription may reveal an expectation that care would stop all change. Revisit that expectation before assuming the family is dissatisfied with the same outcome the clinician is evaluating.

Check whether the written instructions matched life at home. A practical barrier can require another teaching or treatment discussion. It should not be hidden behind a label such as “noncompliant.”

Use the measurement guide for trend interpretation and the billing guide for fee questions. Keeping those tasks clear prevents one explanation from having to do everything.

The consultation worksheet is a prompt for checking the discussion, not a patient risk calculator. It stores and transmits no responses.